Wenwei Liang

Title: Innovations of Wenwei Liang in Oral Drug Delivery Systems.

Introduction

Wenwei Liang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug delivery systems. His innovative approach focuses on enhancing the efficacy of insoluble drugs through advanced sustained-release compositions.

Latest Patents

Wenwei Liang holds a patent for an "Oral sustained-release composition for insoluble drug, and preparation method thereof." This patent discloses a composition that is especially suitable for low-dose insoluble drugs. The oral sustained-release composition comprises a sustained-release granule part and a gel skeleton part. The sustained-release granule part includes the insoluble drug, an enteric material, and a strong liquid sorbent. The gel skeleton part consists of a hydrophilic gel skeleton material. The preparation process involves creating a suspension of the insoluble drug and the enteric material, which is then sprayed onto the strong liquid sorbent. This innovative system prolongs the release time of the drug while ensuring high efficiency and uniform mixing, with minimal content loss.

Career Highlights

Wenwei Liang has worked with prominent companies in the pharmaceutical industry, including Diqi Pharmaceuticals Co., Ltd. and Guangzhou Diqi Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of drug delivery technologies.

Collaborations

Wenwei Liang has collaborated with notable professionals in his field, including Xiaofeng Tan and Feng Liu. These collaborations have further enriched his research and development efforts, leading to innovative solutions in pharmaceutical formulations.

Conclusion

Wenwei Liang's contributions to the field of oral drug delivery systems highlight his innovative spirit and dedication to improving pharmaceutical technologies. His patent for a sustained-release composition demonstrates his commitment to enhancing the efficacy of insoluble drugs.